Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not α-synuclein-induced neuronal cell loss. uri icon

authors

  • McFarland, Nikolaus R
  • Hirst, Warren
  • McLean, Pamela J
  • Dimant, Hemi
  • Kibuuka, Laura
  • Ebrahimi-Fakhari, Darius
  • Desjardins, Cody A
  • Danzer, Karin M
  • Danzer, Michael
  • Fan, Zhanyun
  • Michael Schwarzschild, MD, PhD

publication date

  • January 1, 2014